ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer

References

• Jayson GC, Kohn EC, Kitchener HC, et al. Ovarian cancer. Lancet. 2014;384(9951):1376–1388.
   PubMed Web of Science ®Google Scholar
• Lheureux S, Gourley C, Vergote I, et al. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240–1253.
   PubMed Web of Science ®Google Scholar
• Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin. 2011;61(3):183–203.
   PubMed Web of Science ®Google Scholar
• Dizon DS. PARP inhibitors for targeted treatment in ovarian cancer. Lancet. 2017;390(10106):1929–1930.
   PubMed Web of Science ®Google Scholar
• Zhang M, Song Y, Yu L. LncRNA PTCSC3 suppressed cervical carcinoma cell invasion and proliferation via regulating miR-574-5p. Am J Transl Res. 2019;11(11):7186–7194.
   PubMed Web of Science ®Google Scholar
• Yuan L, Ma T, Liu W, et al. LINC00994 promoted invasion and proliferation of gastric cancer cell via regulating miR-765-3p. Am J Transl Res. 2019;11(10):6641–6649.
   PubMed Web of Science ®Google Scholar
• Yin X, Zhang J, Li C, et al. LncRNA HOXA11-AS accumulation-induced microRNA-761 downregulation regulates cell growth by targeting TRIM29 in papillary thyroid cancer. Am J Transl Res. 2019;11(11):6826–6837.
   PubMed Web of Science ®Google Scholar
• Yang Q, Sun J, Ma Y, et al. LncRNA DLX6-AS1 promotes laryngeal squamous cell carcinoma growth and invasion through regulating miR-376c. Am J Transl Res. 2019;11(11):7009–7017.
   PubMed Web of Science ®Google Scholar
• Lei X, Yang S, Yang Y, et al. Long noncoding RNA DLX6-AS1 targets miR-124-3p/CDK4 to accelerate Ewing’s sarcoma. Am J Transl Res. 2019;11(10):6569–6576.
   PubMed Web of Science ®Google Scholar
• Wang JY, Lu AQ, Chen LJ. LncRNAs in ovarian cancer. Clin Chim Acta. 2019;490:17–27.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun J, Yu J, et al. LncRNA CACS15 accelerates the malignant progression of ovarian cancer through stimulating EZH2-induced inhibition of APC. Am J Transl Res. 2019;11(10):6561–6568.
   PubMed Web of Science ®Google Scholar
• Li Y, Jiao Y, Hao J, et al. Long noncoding RNA TP73-AS1 accelerates the epithelial ovarian cancer via epigenetically repressing p21. Am J Transl Res. 2019;11(4):2447–2454.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang R, Li SJ. Long noncoding RNA SNHG14 promotes ovarian cancer cell proliferation and metastasis via sponging miR-219a-5p. Eur Rev Med Pharmacol Sci. 2019;23(10):4136–4142.
   PubMed Web of Science ®Google Scholar
• Yan H, Li H, Li P, et al. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis. J Exp Clin Cancer Res. 2018;37(1):237.
   PubMedGoogle Scholar
• Dong L, Ding C, Zheng T, et al. Extracellular vesicles from human umbilical cord mesenchymal stem cells treated with siRNA against ELFN1-AS1 suppress colon adenocarcinoma proliferation and migration. Am J Transl Res. 2019;11(11):6989–6999.
   PubMed Web of Science ®Google Scholar
• Liu JX, Li W, Li JT, et al. Screening key long non-coding RNAs in early-stage colon adenocarcinoma by RNA-sequencing. Epigenomics. 2018;10(9):1215–1228.
   PubMed Web of Science ®Google Scholar
• Polev DE, Karnaukhova IK, Krukovskaya LL, et al. ELFN1-AS1: a novel primate gene with possible microRNA function expressed predominantly in human tumors. Biomed Res Int. 2014;2014:398097.
   PubMed Web of Science ®Google Scholar
• Lei R, Feng L, Hong D. ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644/TRIM44 axis. Cancer Biomark. 2020;27(4):433–443.
   PubMed Web of Science ®Google Scholar
• Zhang C, Lian H, Xie L, et al. LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p. Biol Chem. 2019. In press.
   Web of Science ®Google Scholar
• Paraskevopoulou MD, Vlachos IS, Karagkouni D, et al. DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts. Nucleic Acids Res. 2016;44(D1):D231–D238.
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam J-W, et al. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 2015;4. DOI:10.7554/eLife.05005.
   Web of Science ®Google Scholar
• Tripathi MK, Doxtater K, Keramatnia F, et al. Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes. Drug Discov Today. 2018;23(9):1635–1643.
   PubMed Web of Science ®Google Scholar
• Liu E, Liu Z, Zhou Y. Carboplatin-docetaxel-induced activity against ovarian cancer is dependent on up-regulated lncRNA PVT1. Int J Clin Exp Pathol. 2015;8(4):3803–3810.
   PubMed Web of Science ®Google Scholar
• Li W, Ma S, Bai X, et al. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer. J Cell Physiol. 2020;235(2):1141–1154.
   PubMed Web of Science ®Google Scholar
• Liu X, Wen J, Wang H, et al. Long non-coding RNA LINC00460 promotes epithelial ovarian cancer progression by regulating microRNA-338-3p. Biomed Pharmacothe. 2018;108:1022–1028.
   PubMed Web of Science ®Google Scholar
• Cui X, Yu T, Shang J, et al. Long non-coding RNA CDKN2B-AS1 facilitates laryngeal squamous cell cancer through regulating miR-497/CDK6 pathway. Onco Targets Ther. 2019;12:8853–8862.
   PubMed Web of Science ®Google Scholar
• Cui Z, Han B, Wang X, et al. Long non-coding RNA TTN-AS1 promotes the proliferation and invasion of colorectal cancer cells by activating miR-497-mediated PI3K/Akt/mTOR signaling. Onco Targets Ther. 2019;12:11531–11539.
   PubMed Web of Science ®Google Scholar
• Gao H, Yang JY, Tong LX, et al. Long noncoding RNA UCA1 promotes proliferation and metastasis of thyroid cancer cells by sponging miR-497-3p. Eur Rev Med Pharmacol Sci. 2020;24(2):728–734.
   PubMed Web of Science ®Google Scholar
• Li J, Chigurupati S, Agarwal R, et al. Possible angiogenic roles for claudin-4 in ovarian cancer. Cancer Biol Ther. 2009;8(19):1806–1814.
   PubMed Web of Science ®Google Scholar
• Shang X, Lin X, Alvarez E, et al. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases. Neoplasia. 2012;14(10):974–985.
   PubMed Web of Science ®Google Scholar